This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a fluorine atom and a methoxy group, makes it a valuable intermediate in the development of drugs targeting the central nervous system (CNS). It is particularly significant in the production of compounds with potential antidepressant, antipsychotic, or analgesic properties. Additionally, its chiral nature allows for the creation of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. The compound is also explored in research for its potential use in designing novel therapeutic agents for neurological disorders.